Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet
Clinical trial NCT00917644 · COMPLETED
Trial details
- NCT number
- NCT00917644
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2008-09-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.